Volume 64, Issue 5 pp. 671-682
Original Article

Childhood hepatocellular carcinoma: a clinicopathological study of 12 cases with special reference to EpCAM

Yoh Zen

Corresponding Author

Yoh Zen

Histopathology Section, Institute of Liver Studies, King's College Hospital, London, UK

Address for correspondence: Y Zen, MD, PhD, FRCPath, Institute of Liver Studies, King's College Hospital, Denmark Hill, London SE5 9RS, UK. e-mail: [email protected]Search for more papers by this author
Roshni Vara

Roshni Vara

Department of Inherited Metabolic Disease, Evelina Children's Hospital, St Thomas’ Hospital, London, UK

Search for more papers by this author
Bernard Portmann

Bernard Portmann

Histopathology Section, Institute of Liver Studies, King's College Hospital, London, UK

Search for more papers by this author
Nedim Hadzic

Nedim Hadzic

Paediatric Centre for Hepatology, Gastroenterology and Nutrition, King's College Hospital, London, UK

Search for more papers by this author
First published: 19 October 2013
Citations: 32

Abstract

Aims

To elucidate the characteristics of hepatocellular carcinoma (HCC) in children.

Methods and results

A retrospective search of our database identified 12 children with HCC (aged 10 months to 11 years; male/female ratio of 5:7). Their pathological features were compared with those of adult HCCs (n = 20), fibrolamellar HCCs (n = 14), and hepatoblastomas (n = 15). All childhood HCCs developed on a background of cirrhosis resulting from tyrosinaemia type 1 (n = 4), bile salt export transporter deficiency (n = 4), biliary atresia (n = 3), and long-standing total parenteral nutrition (n = 1). HCCs in cases of tyrosinaemia type 1 always had clear cell changes, solid architecture, and only mild nuclear atypia, whereas the morphological features of HCCs in the other conditions were basically similar to those of adult HCCs. On immunostaining, all cases of childhood HCC were positive for epithelial cell adhesion molecule (EpCAM); expression was diffuse (>50% of cancer cells) in 11 cases, and particularly strong in six children, all aged <3 years. In contrast, EpCAM was only focally expressed in three cases of adult HCC (15%). EpCAM was also expressed in most fibrolamellar HCCs and hepatoblastomas, but these two neoplasms differed from childhood HCCs in the expression of CK7, β-catenin, and p53.

Conclusions

The diffuse expression of EpCAM characterizes childhood HCC, and may indicate immaturity of neoplastic cells.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.